Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4′‐tetramethoxystilbene (DMU‐212) on adenoma development in the ApcMin+ mouse and cyclooxygenase‐2 in human‐derived colon cancer cells
- 1 February 2005
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 115 (2), 194-201
- https://doi.org/10.1002/ijc.20884
Abstract
Naturally occurring molecules with putative cancer chemopreventive properties such as the phytoalexin resveratrol (3,5,4′‐trihydroxystilbene) are lead molecules that guide the design of novel agents with improved pharmacologic properties. The synthetic resveratrol analog 3,4,5,4′‐tetramethoxystilbene (DMU‐212) has been shown to possess stronger antiproliferative properties in human colon cancer cells than resveratrol. We tested the hypothesis that DMU‐212 is also a more potent inhibitor of adenoma development in the ApcMin+ mouse, a model of human intestinal carcinogenesis. ApcMin+ mice received either stilbene derivative with the diet (0.2%), and adenomas were counted after experiments were terminated. Resveratrol and DMU‐212 decreased adenoma load by 27% and 24%, respectively, compared to untreated controls. Cyclooxygenase (COX) enzymes are important mechanistic targets of resveratrol, and we investigated whether DMU‐212 interferes with the expression and activity of COX in human colon cells. Incubation of HCA‐7 cancer cells for 24–96 hr with either stilbene derivative (1–50 μM) decreased prostaglandin E‐2 (PGE‐2) production, but only resveratrol decreased COX‐2 protein expression. In mice, which received either stilbene derivative (0.2%) for 3 weeks with their diet, PGE‐2 levels in the intestinal mucosa were reduced by between 45% and 62% compared to mice on control diet. While resveratrol inhibited enzyme activity in purified COX preparations, DMU‐212 failed to do so. The PGE‐2 decrease seen with DMU‐212 in cells and in vivo is probably mediated via its metabolites. The results suggest that alteration of the resveratrol molecule to generate DMU‐212 does not abrogate its ability to decrease adenoma number in ApcMin+ mice or to interfere with PGE‐2 generation in cells.Keywords
This publication has 38 references indexed in Scilit:
- Insulin Secretion and Cyclooxygenase Enzyme Inhibition by Cabernet Sauvignon Grape Skin CompoundsJournal of Agricultural and Food Chemistry, 2003
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- Inhibition of cell transformation by resveratrol and its derivatives: differential effects and mechanisms involvedOncogene, 2003
- μ-Calpain Activation in β-Lapachone-Mediated ApoptosisCancer Biology & Therapy, 2003
- Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapseInternational Journal of Cancer, 2001
- Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expressionCarcinogenesis: Integrative Cancer Research, 2000
- Antimutagenic effect of resveratrol against Trp-P-1Mutation Research, 1997
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997
- Isolation and characterization of multiple cell types from a single human colonic carcinoma: Tumourigenicity of these cell types in a xenograft systemThe Journal of Pathology, 1993
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976